Reckitt Benckiser Group PLC (RBGLY)
10.94
+0.17
(+1.58%)
USD |
OTCM |
Apr 24, 14:30
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 38.59B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -31.35% |
| Valuation | |
| PE Ratio | 19.14 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.156 |
| Price to Book Value | 3.586 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.2941 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.9718 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 43.47% |
Profile
| Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets. |
| URL | https://www.reckitt.com |
| Investor Relations URL | https://www.reckitt.com/investors/ |
| HQ State/Province | N/A |
| Sector | Consumer Staples |
| Industry | Household Products |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Jul. 26, 2024 (est.) |
| Last Earnings Release | Feb. 28, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 11, 2024 |
Ratings
Profile
| Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets. |
| URL | https://www.reckitt.com |
| Investor Relations URL | https://www.reckitt.com/investors/ |
| HQ State/Province | N/A |
| Sector | Consumer Staples |
| Industry | Household Products |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Jul. 26, 2024 (est.) |
| Last Earnings Release | Feb. 28, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 11, 2024 |